Skip to content
★ Sign in to follow
HLB제넥스 logo

HLB제넥스 Stock: price and insider trades · South Korea

KR·Mcap ₩77BChemicals

No insider purchase over the last 90 days. The latest, by 진양곤, was filed 29 Jul 2026.

HLB제넥스: what insiders have been doing

Every trade that managers of HLB제넥스 disclose to DART (FSS) is tracked on this page. The company sits in the Chemicals sector. Over the twelve months to 2 November 2026, 29 filings were filed, from 8 insiders.

Both sides are active: 25 purchases worth €1.4M and 3 sales, from 7 insiders and 2 insiders respectively. The totals exclude 20 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 3 chief executives, 2 board members and 1 major shareholder. One trade stands out by size: a purchase of €496k from Hlb, disclosed on 19 March 2026, or 1.4% of market capitalisation.

Within a 30-day window, 5 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 29 July 2026, 102 days ago. Typically, a trade is published a median of 7 days after it takes place. That lag is the time during which only the insider knows about the trade.

Compared with its exchange (2,655 companies, median 7 filings), a count of 29 filings is above the norm. Our records for HLB제넥스 go back to 2021, with 42 purchases and 18 sales on the open market in total.

Elsewhere in the same sector, our signals recently picked up insider purchases at Symrise AG and Titan. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
67
Thresholds
n/a
Buy Volume
€48M
42 ops. · all time
Sell Volume
€38M
18 ops. · all time

Who traded when

BuySale
Hlb19 buys2 sales
진양곤10 buys
김도연5 buys
김의중2 buys2 sales
반재구1 buy1 sale
아르마트 신기술조합 제304호1 buy1 sale

Since the insiders bought

  • Filed 16 Jul 2026 · 115 days ago · €32k
    +43.7%
    Entry ₩1,642 · Close 30 Oct 2026 ₩2,360
  • Filed 02 Jul 2026 · 129 days ago · €30k
    +19.7%
    Entry ₩1,972 · Close 30 Oct 2026 ₩2,360
  • Filed 29 Jun 2026 · 132 days ago · €31k
    +16.3%
    Entry ₩2,030 · Close 30 Oct 2026 ₩2,360

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 1,201 of 26,897 companies
79.7
score / 100
Value
85
Quality
74
FCF yld3.7%
Earn yld35%
EV/EBITDA2.8x
ROE17%
Gross mgn35%
Net mgn52%
Debt/EBITDA1.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩2,360
Analyst consensus
·
Income statement
Revenue₩43.4B
Gross profit₩15.2B35% margin
EBITDA₩39.4B91% margin
Net income₩22.6B20.3% margin
Valuation
Beta0.07
Balance sheet & cash
Market cap₩77B
Total debt₩43.5B
Free Cash Flow₩2.4B
Debt / Equity61%
Profitability & ownership
ROE16.7%
ROA0.5%
% insiders35.4%
% institutions0.0%
Last declaration on 6 August 2026
Declarations74 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▼
    사실상지배주주Executives(filed)
    €2.3Mest.0DART
    2,252,252 sharesShareKRXDART:20260806000376
  • Other
    Other(filed)
    0DART
  • ▲
    사내이사Executives(filed)
    €43kest.0DART
    50,428 sharesShareKRXDART:20260729000356
    Canonical exit: 27 Oct 2026 (T+90)
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    대표이사Executives(filed)
    €32kest.0DART
    32,567 sharesShareKRXDART:20260716000188
    Canonical exit: 14 Oct 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    사내이사Executives(filed)
    €30kest.0DART
    27,000 sharesShareKRXDART:20260702000134
    Canonical exit: 30 Sept 2026 (T+90)
  • ▲
    대량보유자Executives(filed)
    €31kest.0DART
    27,000 sharesKRXDART:20260629000098
    Canonical exit: 27 Sept 2026 (T+90)
  • ▲
    사실상지배주주Executives(filed)
    €847kest.0DART
    720,000 sharesShareKRXDART:20260623000396
    Canonical exit: 21 Sept 2026 (T+90)
  • ▲
    대량보유자Executives(filed)
    €986kest.0DART
    744,424 sharesKRXDART:20260618000220
    Canonical exit: 16 Sept 2026 (T+90)
  • ▲
    사내이사Executives(filed)
    €19kest.0DART
    14,000 sharesShareKRXDART:20260617000158
    Canonical exit: 15 Sept 2026 (T+90)
  • ▲
    사내이사Executives(filed)
    €132kest.0DART
    103,735 sharesShareKRXDART:20260610000462
    Canonical exit: 8 Sept 2026 (T+90)
  • ▲
    대량보유자Executives(filed)
    €132kest.0DART
    103,735 sharesKRXDART:20260609000150
    Canonical exit: 7 Sept 2026 (T+90)
  • ▲
    사내이사Executives(filed)
    €15kest.0DART
    14,000 sharesShareKRXDART:20260605000088
    Canonical exit: 3 Sept 2026 (T+90)
  • ▲
    대량보유자Executives
    €15kest.0DART
    14,000 sharesKRXDART:20260602000097
    Canonical exit: 30 Aug 2026 (T+90)
  • ▲
    Executives
    €23kest.0DART
    21,035 sharesKRXDART:20260526000390
    Canonical exit: 16 Aug 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €27kest.0DART
    21,035 sharesShareKRXDART:20260520000050
    Canonical exit: 18 Aug 2026 (T+90)
  • ▲
    대표이사Executives
    51M KRW45DART
    15,556 shares@ ₩3,277.000.086% mcap100.0% of flowShareKRXDART:20260422000053
    Canonical exit: 21 Jul 2026 (T+90)
  • ▲
    Executives
    €29k14DART
    15,556 shares0.086% mcap2.6% of flowKRXDART:20260421000005
    Canonical exit: 19 Jul 2026 (T+90)
  • ▲
    사내이사Executives
    194M KRW27DART
    68,401 shares@ ₩2,831.0520.32% mcap100.0% of flowShareKRXDART:20260416000511
    Canonical exit: 14 Jul 2026 (T+90)

25 of 74 declarations

About HLB제넥스

HLB제넥스 is a company operating in the chemical and materials sector. It is listed on the XKRX market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations